Earnings Call · Q2 FY2024·2024-08-13

Q2 24EPS -6.67%·Rev n/aQ1 24EPS -31.36%·Rev n/aQ4 23EPS -7.02%·Rev n/aQ3 23EPS -86.07%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Jim Caruso — Chief Executive Officer

Chad Kolean — Chief Financial Officer

Andrei Shustov — Senior Vice President, Medical

Jarrod Longcor — Chief Operating Officer

Shane Lea — Chief Commercial Officer

+8.6%1d on move date+7.0% vs SPY3d+9.1%5d+10.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access